Physician

Farhana Latif, M.D.

According to 2025 Medicare claims, Farhana Latif, M.D. (NPI: 1578728952) practices advanced heart failure and transplant cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (NPI: 1861907321; TIN: 135598093) and primary practice location at 10032-3739. Latif is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Latif's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 456 HCPCS/CPT codes, and received $57,439 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 366 prescription claims across 82 beneficiaries totaling $789,495 in drug costs, led by Panzyga (Immun Glob G(Igg)-Ifas/Glycine). DME data shows 22 claims. Open Payments data shows 29 records totaling $1,545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $91,941 to $57,439. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $359,580 and ending at $789,495. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,779 to $694.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	201	846	$91,941
2016	204	1,023	$119,094
2017	188	816	$78,405
2018	196	786	$87,707
2019	125	352	$37,238
2020	167	573	$55,793
2021	180	617	$66,119
2022	174	561	$56,192
2023	153	422	$50,235
2024	162	456	$57,439

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	67	308	$359,580
2016	64	288	$45,913
2017	43	259	$21,173
2018	54	306	$39,592
2019	32	146	$24,367
2020	34	162	$156,606
2021	41	191	$16,433
2022	77	297	$226,377
2023	111	625	$892,790
2024	82	366	$789,495

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	110	$54,429
2016	N/R	113	$33,488
2017	N/R	40	$1,154
2018	N/R	82	$4,937
2019	N/R	N/R	N/R
2020	N/R	11	$211
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	123	$3,302
2024	N/R	22	$390

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	33	103	$199
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	17	18	$173
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	35	110	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	79	143	$109
36415	Insertion of needle into vein for collection of blood sample	17	18	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Panzyga	Immun Glob G(Igg)-Ifas/Glycine	24	672	$354,761
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	24	672	$280,285
Entresto	Sacubitril/Valsartan	42	1,440	$30,817
Verquvo	Vericiguat	11	320	$7,647
Amlodipine Besylate	Amlodipine Besylate	21	1,355	$211

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$265
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	11	$125

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$1,545	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Farhana Latif, M.D.?

Tedicare shows public-source Medicare data for Farhana Latif, M.D. (NPI 1578728952), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Farhana Latif, M.D. have ACO affiliation data?

Farhana Latif, M.D. is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Farhana Latif, M.D.?

Farhana Latif, M.D. is linked to TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (billing NPI 1861907321) in the available physician profile data.

Does Farhana Latif, M.D. have Open Payments data?

Farhana Latif, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.